Trial intelligence / Profile preview

Dexmedetomidine for prevention of postoperative delirium after hip surgery in elderly patients

TCTR20260828004Phase 4Recruiting

Sponsor
N/A
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in postoperative delirium (POD), sponsored by N/A. Started Dec 2025; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on TCTR20260828004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260828004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call